Cetera Investment Advisers’s Blueprint Medicines BPMC Stock Holding History

Cetera Investment Advisers’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,388	Closed	-$819K	–	4580
2025 Q2	$819K	Sell	6,388 -470	-7%	-$48.8K	﹤0.01%	2552
2025 Q1	$607K	Sell	6,858 -3	-0%	-$293	﹤0.01%	2680
2024 Q4	$598K	Sell	6,861 -241	-3%	-$22.1K	﹤0.01%	2547
2024 Q3	$657K	Buy	7,102 +192	+3%	+$19.1K	﹤0.01%	2430
2024 Q2	$745K	Sell	6,910 -1,411	-17%	-$141K	﹤0.01%	2287
2024 Q1	$789K	Buy	+8,321	New	+$714K	﹤0.01%	2254

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cetera Investment Advisers's BPMC Position: Q3 2025 in Review

Cetera Investment Advisers sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 6,388 shares — an estimated $819K sold.

Cetera Investment Advisers first reported a position in BPMC in Q1 2024 and held it in 6 quarters. The position peaked at $819K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Cetera Investment Advisers reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Cetera Investment Advisers sold 6,388 Blueprint Medicines shares in Q3 2025, an estimated $819K.
Cetera Investment Advisers first reported a position in Blueprint Medicines in Q1 2024 and held it in 6 quarters.
Cetera Investment Advisers's Blueprint Medicines position peaked at $819K in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Cetera Investment Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.